Stockreport

United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen...

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF 130.1 mL and reduced the risk of clinical worsening in patients with idiopathic pulmonary fibrosis, with positive results observed across all subgroups Integrated anal [Read more]